Meteora Capital’s Aimei Health Technology Co AFJK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-12,196
Closed -$138K 418
2025
Q3
$138K Sell
12,196
-3,748
-24% -$42.2K 0.01% 177
2025
Q2
$176K Sell
15,944
-42,118
-73% -$467K 0.03% 100
2025
Q1
$639K Sell
58,062
-34,348
-37% -$372K 0.21% 71
2024
Q4
$989K Sell
92,410
-78,543
-46% -$831K 0.33% 69
2024
Q3
$1.79M Buy
+170,953
New +$1.78M 0.5% 69

Other funds holding AFJK

Meteora Capital's AFJK Position: Q4 2025 in Review

Meteora Capital sold out of Aimei Health Technology Co (AFJK) in Q4 2025, closing a stake of 12,196 shares — an estimated $138K sold.

Meteora Capital first reported a position in AFJK in Q3 2024 and held it in 5 quarters. The position peaked at $1.79M in Q3 2024. 11 funds tracked by Wall St. Rank hold AFJK as of Q4 2025.

  • Meteora Capital reported no remaining Aimei Health Technology Co position as of Q4 2025 after selling out during the quarter.
  • Meteora Capital sold 12,196 Aimei Health Technology Co shares in Q4 2025, an estimated $138K.
  • Meteora Capital first reported a position in Aimei Health Technology Co in Q3 2024 and held it in 5 quarters.
  • Meteora Capital's Aimei Health Technology Co position peaked at $1.79M in Q3 2024.
  • 11 funds tracked by Wall St. Rank held Aimei Health Technology Co as of Q4 2025.

Based on Meteora Capital's 13F filing for Q4 2025, filed 17 Feb 2026.